| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.087 | 0.1 |